We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Declines to Dismiss Toprol Suit as FDA Approves Generic Version
Court Declines to Dismiss Toprol Suit as FDA Approves Generic Version
April 27, 2010
A federal court has denied AstraZeneca’s motion to dismiss a class action accusing the company of delaying the introduction of a generic version of its Toprol-XL hypertension treatment, while the FDA has approved a generic version of the drug.